Lymphocyte cholecystokinin concentrations in panic disorder. 1993

F Brambilla, and L Bellodi, and G Perna, and A Garberi, and A Panerai, and P Sacerdote
Centro di Psiconeuroendocrinologia, Ospedale Psichiatrico Pini, Milan, Italy.

Since cholecystokinin (CCK) is known to be anxiogenic in experimental animals and to induce panic attacks in humans, lymphocyte CCK-8 concentrations were measured in 15 patients with panic disorder and 15 age- and sex-matched healthy subjects. The patients' levels were measured again after a 30-day course of alprazolam therapy, 1.5 mg/day. The CCK-8 concentrations were significantly lower in the patients than in the control subjects and did not change after alprazolam therapy. There was no correlation between the peptide values and levels of anxiety or frequency and severity of panic attacks.

UI MeSH Term Description Entries
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D008297 Male Males
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000525 Alprazolam A triazolobenzodiazepine compound with antianxiety and sedative-hypnotic actions, that is efficacious in the treatment of PANIC DISORDERS, with or without AGORAPHOBIA, and in generalized ANXIETY DISORDERS. (From AMA Drug Evaluations Annual, 1994, p238) Alprazolan,Alprox,Apo-Alpraz,Cassadan,D-65MT,Esparon,Kalma,Novo-Alprazol,Nu-Alpraz,Ralozam,Tafil,Trankimazin,U-31,889,Xanax,Apo Alpraz,D65MT,Novo Alprazol,Nu Alpraz,U31,889
D012720 Severity of Illness Index Levels within a diagnostic group which are established by various measurement criteria applied to the seriousness of a patient's disorder. Illness Index Severities,Illness Index Severity
D012844 Sincalide An octapeptide hormone present in the intestine and brain. When secreted from the gastric mucosa, it stimulates the release of bile from the gallbladder and digestive enzymes from the pancreas. CCK-8,Cholecystokinin Octapeptide,CCK-OP,Cholecystokinin Pancreozymin C-Terminal Octapeptide,H-Asp-Tyr(SO3H)-Met-Gly-Trp-Met-Asp-Phe-NH2,Kinevac,OP-CCK,SQ-19,844,SQ-19844,Syncalide,Cholecystokinin Pancreozymin C Terminal Octapeptide,SQ 19,844,SQ 19844,SQ19,844,SQ19844

Related Publications

F Brambilla, and L Bellodi, and G Perna, and A Garberi, and A Panerai, and P Sacerdote
April 2004, Acta neuropsychiatrica,
F Brambilla, and L Bellodi, and G Perna, and A Garberi, and A Panerai, and P Sacerdote
March 2000, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology,
F Brambilla, and L Bellodi, and G Perna, and A Garberi, and A Panerai, and P Sacerdote
May 1992, The American journal of psychiatry,
F Brambilla, and L Bellodi, and G Perna, and A Garberi, and A Panerai, and P Sacerdote
January 2004, Journal of neural transmission. Supplementum,
F Brambilla, and L Bellodi, and G Perna, and A Garberi, and A Panerai, and P Sacerdote
February 1990, Canadian journal of psychiatry. Revue canadienne de psychiatrie,
F Brambilla, and L Bellodi, and G Perna, and A Garberi, and A Panerai, and P Sacerdote
September 2000, Regulatory peptides,
F Brambilla, and L Bellodi, and G Perna, and A Garberi, and A Panerai, and P Sacerdote
May 1999, Molecular psychiatry,
F Brambilla, and L Bellodi, and G Perna, and A Garberi, and A Panerai, and P Sacerdote
March 1994, Annals of the New York Academy of Sciences,
F Brambilla, and L Bellodi, and G Perna, and A Garberi, and A Panerai, and P Sacerdote
December 1994, Progress in neuro-psychopharmacology & biological psychiatry,
F Brambilla, and L Bellodi, and G Perna, and A Garberi, and A Panerai, and P Sacerdote
August 1996, European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology,
Copied contents to your clipboard!